The contribution of HLA molecules to Dupuytren's contracture in a Southeast Brazilian population

被引:0
|
作者
Ruiz Silva Uso, Sonia Maria [1 ,2 ]
Santos Sanson, Ana Claudia [2 ]
Covolo-Santana, Fabiana de Souza [2 ]
Camarinha Marcos, Elaine Valim [1 ]
Marques, Tatiani [3 ]
Cury Filho, Milton [3 ]
Ura, Somei [4 ]
机构
[1] Univ Estadual Paulista UNESP, Sch Med, Botucatu, SP, Brazil
[2] Inst Lauro de Souza Lima, Immunogenet Lab, Bauru, SP, Brazil
[3] Inst Lauro de Souza Lima, Rehabil Dept, Bauru, SP, Brazil
[4] Inst Lauro de Souza Lima, Bauru, SP, Brazil
关键词
Dupuytren's contracture; HLA; Major histocompatibility complex; Disease association; Immunogenetics; GENETIC SUSCEPTIBILITY; GROWTH-FACTOR; DISEASE; ASSOCIATION; EXPRESSION; MANAGEMENT; ARTHRITIS; ALLELES;
D O I
10.1016/j.rbre.2014.02.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The aim of the present study was to investigate the HLA phenotype in Dupuytren's contracture (DC) patients in order to verify the correlation of these alleles with risk factors for development of DC in the Brazilian population. Methods: This was a case-controlled study of 25 DC patients and 443 healthy individuals with no history of HLA-associated diseases. HLA class I and class II typing was performed using the polymerase chain reaction sequence-specific primer method. Results: The HLA-B*18 phenotype was observed in 32% of the patients and 10.5% of controls. However, P values did not remain significant after correction. Discussion: Although we observed an increased tendency of DC patients to possess the HLA-B*18 allele, the results were not statistically significant after correction. This allele was higher in patients of Italian and/or Spanish ethnicity, localities with frequencies higher than 18.0% and 14.0% respectively. Further investigation with a larger cohort of DC patients is required to confirm the potential role of HLA in this disease. (C) 2014 Elsevier Editora Ltda. All rights reserved.
引用
收藏
页码:38 / 43
页数:6
相关论文
共 50 条
  • [41] Dupuytren's Contracture: A Guide for Management
    Beredjiklian, Pedro K.
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (01) : 309 - 311
  • [42] Factors in the pathogenesis of Dupuytren's contracture
    Al-Qattan, Mohammad M.
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2006, 31A (09): : 1527 - 1534
  • [43] Dupuytren-KontrakturDupuytren’s Contracture
    Zeitschrift für Allgemeinmedizin, 2012, 88 (9): : 343 - 344
  • [44] Update on the management of Dupuytren's contracture
    Vi, Linda
    O'Gorman, David B.
    Gan, Bing Siang
    ORTHOPEDIC RESEARCH AND REVIEWS, 2010, 2 : 35 - 43
  • [45] The ''S'' Quattro in severe Dupuytren's contracture
    Beard, AJ
    Trail, IA
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1996, 21B (06): : 795 - 796
  • [46] Commentary: Dupuytren's disease vs non-Dupuytren's contracture
    Rayan, GM
    JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 2005, 30A (05): : 1019 - 1020
  • [47] Treatment of Dupuytren's contracture [Behandeling van contracturen van Dupuytren]
    Bekkering A.
    Wubbels S.
    Meijer M.
    Schermer T.
    Huisarts en wetenschap, 2015, 58 (8) : 406 - 412
  • [48] Bilateral Dupuytren's contracture in a black patient
    Aladin, A
    Oni, JA
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (09) : 641 - 642
  • [49] Bloodless treatment of Dupuytren's finger contracture
    Lengemann, P
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1903, 29 : 407 - 408
  • [50] A clinical grading system for Dupuytren's contracture
    Woodruff, MJ
    Waldram, MA
    JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 1998, 23B (03): : 303 - 305